Home > Conference information > Committees

Scientific Program Committee

Jie Chen (Co-chair)	Merck & Co., Inc.
Toshimitsu Hamasaki (Co-chair)	National Cerebral and Cardiovascular Center
Satoshi Morita (Co-chair)	Kyoto University

Yuki Ando	Pharmaceuticals and Medical Devices Agency
Scott Berry	Berry Consulting
Ivan S. F. Chan	AbbVie
Alan Chiang	Celgene Corporation
Luyan Dai	Harbour Biomed
Jie Ding	MSD China
Scott R. Evans	George Washington University
Frank Fan	Novartis
Tony Guo	BeiGene
Susan Halabi	Duke University
Lisa Hampson	Novartis AG
Chin-Fu Hsiao	National Health Research Institutes
HM James Hung	Food and Drug Administration
Seung-Ho Kang	Yonsei University
Florian Klinglmueller	Austrian Medicines & Medical Devices Agency
Franz Köenig	Medical University of Vienna
Ying Lu	Stanford University
Olga Marchenko	Bayer
Sandeep Menon	Pfizer Inc.
Guo Tong	IQVIA
Mey Wang	The Center for Drug Evaluation, Taiwan
William Wang	Merck & Co., Inc.
Jiawei Wei	Novartis Institutes for BioMedical Research
Haiyan Xu	Johnson and Johnson
Guosheng Yin	The University of Hong Kong
Ying Yuan	University of Texas MD Anderson Cancer Center
Helen Zhang	University of Arizona
Sarah Zohar	Centre de Recherche des Cordeliers

Short Course Committee

Martin Posch	Medical University of Vienna
Wenjin Wang	Pfizer Inc.

Fundraising Committee

Jie Chen	Merck & Co., Inc.
Toshimitsu Hamasaki	National Cerebral and Cardiovascular Center
Norisuke Kawai	Pfizer Japan Inc.
Akira Wakana	MSD K.K.

Local Organizing Committee

Hiroyasu Abe	Kyoto University
Koko Asakura	National Cerebral and Cardiovascular Center
Kimitoshi Ikeda	AbbVie GK
Naoki Isogawa	Pfizer Japan Inc.
Tomoyuki Kakizume	Novartis Novartis Pharma K.K
Shoichi Ohwada	DaiichiSankyo Company
Kentaro Sakamaki	The University of Tokyo
Masataka Taguri	Yokohama City University
Fumihiro Takahashi	Mitsubishi Tanabe Pharma Corporation
Ryuji Uozumi	Kyoto University

Advisory Board

Frank Bretz	Novartis, AG
Yutaka Matsuyama	The University of Tokyo
Yasuo Ohashi	Chuo University